Bio Matrix Scientific Group Inc (PINK:BMSN) Goes to FDA for Clinical Trials of Highly Anticipated Drug

Las Vegas, NV -- (SBWIRE) -- 02/21/2013 -- Bio Matrix Scientific Group Inc (PINK:BMSN) has recently applied in FDA to initiate clinical trials on HemaXellarate stem cell drug. The application in FDA is officially filed through the company’s fully owned subsidiary Regen BioPharma. The respective drug is used in treatment of patients with drug refractory aplastic anaemia.

Bio Matrix Scientific Group has also recently published a scientific rational for its HemaXellarate product with the help of globally renowned researchers.

The company’s management is very enthusiastic on its new product as the HemaXellerate is believed to be only therapy which has ability to treat aplastic anemia as well rebuilds the bone marrow tissue at the same time.

The share price is up 9.62 percent in today’s session in the morning at $0.0111. Almost 17.03 shares are traded in first hour of the session as compared to its average daily volume of 121.68 million shares.

To find out what OTCMAGIC projects for Bio Matrix Scientific Group Inc for both short term and long term please click here: BMSN

OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in Penny Stocks!

Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.